Pfizer reports 'potential' with COVID-19 candidate vaccine after expanding trial to 44,000 people
Pfizer expects to have data next month on how well its COVID-19 candidate vaccine is protecting people against the coronavirus.
Pfizer reports 'potential' with COVID-19 candidate vaccine after expanding trial to 44,000 people
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
-
Dow ends 400+ points up in reversal of last week's selloff
Proactive Investors
-
Wall Street looking strong to open the week
Proactive Investors
-
Wall Street rises at the opening bell
Proactive Investors
-
Drugmaker Novavax begins late-stage vaccine trial in UK
SeattlePI.com
Advertisement
More coverage
Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trial
WorldNews
AstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19..
